HK1210718A1 - 抗白癬菌症外用液劑 - Google Patents

抗白癬菌症外用液劑

Info

Publication number
HK1210718A1
HK1210718A1 HK15111656.5A HK15111656A HK1210718A1 HK 1210718 A1 HK1210718 A1 HK 1210718A1 HK 15111656 A HK15111656 A HK 15111656A HK 1210718 A1 HK1210718 A1 HK 1210718A1
Authority
HK
Hong Kong
Prior art keywords
antitrichophytosis
solution
external use
external
antitrichophytosis solution
Prior art date
Application number
HK15111656.5A
Other languages
English (en)
Inventor
吉田佳子
小松千記
．嘉屋
高畑祥
田端祐二
Original Assignee
Meiji Seika Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49995097&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1210718(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Meiji Seika Pharma Co Ltd filed Critical Meiji Seika Pharma Co Ltd
Publication of HK1210718A1 publication Critical patent/HK1210718A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK15111656.5A 2012-07-30 2015-11-26 抗白癬菌症外用液劑 HK1210718A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012069306 2012-07-30
PCT/JP2013/070525 WO2014021282A1 (ja) 2012-07-30 2013-07-30 抗白癬菌症外用液剤

Publications (1)

Publication Number Publication Date
HK1210718A1 true HK1210718A1 (zh) 2016-05-06

Family

ID=49995097

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15111656.5A HK1210718A1 (zh) 2012-07-30 2015-11-26 抗白癬菌症外用液劑

Country Status (20)

Country Link
US (1) US20140030209A1 (zh)
EP (1) EP2889031A4 (zh)
JP (1) JP6132842B2 (zh)
KR (1) KR20150038314A (zh)
CN (1) CN104661661A (zh)
AR (1) AR092358A1 (zh)
AU (1) AU2013297602A1 (zh)
BR (1) BR112015001235A2 (zh)
CA (1) CA2879846A1 (zh)
CL (1) CL2015000218A1 (zh)
CO (1) CO7170168A2 (zh)
HK (1) HK1210718A1 (zh)
IL (1) IL236993A0 (zh)
MX (1) MX2015001416A (zh)
PH (1) PH12015500224A1 (zh)
RU (1) RU2015106906A (zh)
SG (1) SG11201500637QA (zh)
TW (1) TW201410239A (zh)
WO (1) WO2014021282A1 (zh)
ZA (1) ZA201500809B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6124892B2 (ja) 2012-07-30 2017-05-10 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 抗白癬菌症貼付剤
US10562858B2 (en) 2014-08-13 2020-02-18 Meiji Seika Pharma Co., Ltd. Crystalline anti-trichophyton agents and preparation process thereof
BR112017019920B1 (pt) 2015-03-19 2023-11-07 Daiichi Sankyo Company, Limited Preparação sólida farmacêutica, e, método para estabilização de uma preparação sólida farmacêutica
US10561628B2 (en) * 2015-03-19 2020-02-18 Daiichi Sankyo Company, Limited Solid preparation including antioxidant
CN107311838A (zh) * 2017-07-13 2017-11-03 柳州丰康泰科技有限公司 一种新的合成环丙基溴的方法
WO2019150485A1 (ja) * 2018-01-31 2019-08-08 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 爪白癬の予防又は治療用外用液剤
TWI845532B (zh) 2018-07-30 2024-06-21 日商第一三共股份有限公司 含安定劑之醫藥品的固體製劑

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3628892A1 (de) * 1986-08-26 1988-03-10 Bayer Ag Substituierte 1-aryl-3-tert.-butyl-pyrazole
ES2015648A6 (es) 1989-05-05 1990-09-01 Consejo Superior Investigacion Procedeimiento de sintesis de mono y bis (3-r3-4-r4-5-r5-pirazol-1-il)1,4-dihidroxibencenos.
US5391367A (en) * 1993-07-28 1995-02-21 Pfizer Inc. Antifungal nail solution
DE4414897A1 (de) 1994-04-28 1995-11-02 Hoechst Ag Aromatische Diazoniumsalze und deren Verwendung in strahlungsempfindlichen Gemischen
JP3729884B2 (ja) 1995-01-05 2005-12-21 関東電化工業株式会社 フルオロフェノール類の製造方法
JPH1160528A (ja) 1997-08-12 1999-03-02 Ube Ind Ltd ４−クロロ−３−トリフルオロメチルフェノールの製法
CA2360354A1 (en) * 1999-01-14 2000-07-20 Sophie-Dorothee Clas Synthesis of 4-[(5-substituted or unsubstituted phenyl)-3-substituted-1h-pyrazol-1-yl] benzenesulfonamides
AU2827100A (en) 2000-03-03 2001-09-17 Sumitomo Chemical Company, Limited Process for the preparation of phenylhydrazines
DE60219793T2 (de) 2001-07-11 2008-01-24 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Verfahren zur Behandlung von Cytokin-Vermittelten Erkrankungen
AU2003271117A1 (en) * 2002-10-09 2004-05-04 Ssp Co., Ltd. Novel pyrazole compounds having antifungal activity
KR100509603B1 (ko) 2002-12-28 2005-08-22 삼성에스디아이 주식회사 적색 발광 화합물 및 이를 채용한 유기 전계 발광 소자
KR101093990B1 (ko) * 2003-03-21 2011-12-16 넥스메드 홀딩스 인코포레이티드 항진균성 네일 코트 및 사용 방법
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
EP1981860B1 (en) 2006-01-19 2011-05-25 Matrix Laboratories Ltd Conversion of aromatic diazonium salt to aryl hydrazine
WO2008024978A2 (en) * 2006-08-24 2008-02-28 Serenex, Inc. Tetrahydroindolone and tetrahydroindazolone derivatives
CN101011560A (zh) * 2007-02-13 2007-08-08 贵州神奇集团控股有限公司 治疗脚手癣、灰指甲的中西复方制剂及其制备方法和质控方法
AU2012209696B2 (en) * 2011-01-30 2015-09-03 Meiji Seika Pharma Co., Ltd. Topical antifungal agent

Also Published As

Publication number Publication date
JPWO2014021282A1 (ja) 2016-07-21
KR20150038314A (ko) 2015-04-08
CL2015000218A1 (es) 2015-05-22
CA2879846A1 (en) 2014-02-06
CN104661661A (zh) 2015-05-27
BR112015001235A2 (pt) 2017-07-04
PH12015500224A1 (en) 2015-04-06
IL236993A0 (en) 2015-03-31
SG11201500637QA (en) 2015-03-30
CO7170168A2 (es) 2015-01-28
EP2889031A4 (en) 2016-01-06
US20140030209A1 (en) 2014-01-30
AR092358A1 (es) 2015-04-15
WO2014021282A1 (ja) 2014-02-06
AU2013297602A1 (en) 2015-02-19
JP6132842B2 (ja) 2017-05-24
ZA201500809B (en) 2016-04-28
TW201410239A (zh) 2014-03-16
MX2015001416A (es) 2015-05-08
EP2889031A1 (en) 2015-07-01
RU2015106906A (ru) 2016-09-20

Similar Documents

Publication Publication Date Title
HK1245780B (zh) 咪唑並吡咯烷酮化合物
HK1203498A1 (zh) 四氫吡唑並嘧啶化合物
EP2925129A4 (en) PRO-NEUROGENIC COMPOUNDS
GB201209138D0 (en) Compounds
GB201214750D0 (en) Compounds
GB201215357D0 (en) Compounds
EP2887803A4 (en) PRO-NEUROGENIC COMPOUNDS
HK1206726A1 (zh) 咪唑並三嗪酮化合物
GB201204985D0 (en) Compounds
HK1210709A1 (zh) 外用組合物
GB201204125D0 (en) Compounds
GB201216800D0 (en) Novel use
HK1211283A1 (zh) 化合物
HK1210718A1 (zh) 抗白癬菌症外用液劑
GB201209096D0 (en) Compounds
HK1206356A1 (zh) -取代的氰基吡唑化合物
GB201219820D0 (en) Compounds
GB201217310D0 (en) Compounds
GB201212463D0 (en) Novel use
GB201214413D0 (en) Festivalstand (festistand)
GB201206393D0 (en) Use
GB201216763D0 (en) Blokprintz (wallblocks)
GB201202256D0 (en) Novel use
GB201223429D0 (en) Compounds
GB201203779D0 (en) (LASERComfortSET)